Martin Crook
Director/Board Member at Cardior Pharmaceuticals GmbH
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Thomas Thum | M | - |
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | 8 years |
Markus Hosang | M | - |
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | - |
Russell Greig | M | 71 |
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | 2 years |
Claudia Ulbrich | M | - |
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | 8 years |
Ulrich Granzer | M | 63 |
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | - |
Johann Bauersachs | M | - |
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | - |
Christoph Broja | M | - |
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | 2 years |
Orly Vardeny | M | - |
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | 2 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Esam Abdulrahim Al-Ghareeb | M | - |
University of Birmingham
| 4 years |
Robert Field | M | - |
University of Bristol
| 8 years |
Tzin Sung Ho | M | 42 |
University of Bristol
| 5 years |
Sergios Katsaros | M | - |
University of Bristol
| 6 years |
Chee Kian Chan | M | 47 |
University of Bristol
| 1 years |
Kai Yu Liu | M | 54 |
University of Birmingham
| 2 years |
Anne Horgan | F | - |
University of Bristol
| 4 years |
King Man Chan | M | 44 |
University of Bristol
| 4 years |
Mbwana Alliy | M | - |
University of Bristol
| 3 years |
Tikhomirova Irina | F | 51 |
University of Lancaster
| 2 years |
Wan bin Wan Hassan | M | 56 |
University of Lancaster
| 4 years |
Luca Salvato | M | - |
University of Bristol
| 3 years |
Sinead Sopala | F | - |
University of Bristol
| 2 years |
Yuk Wong | M | 54 |
University of Lancaster
| 2 years |
Conrado Alba Brunet | M | - |
University of Birmingham
| 1 years |
Thomas William Hulme | M | 48 |
University of Bristol
| 3 years |
Andrew Cormack | M | - |
University of Lancaster
| 3 years |
Jae-Young Park | M | 70 |
University of Birmingham
| 1 years |
Melissa Margaret Scaramellini | F | - |
University of Bristol
| 4 years |
Solitaire Townsend | F | - |
University of Birmingham
| 1 years |
Livio Quintavalle | M | - |
University of Bristol
| 4 years |
Matt Crossman | M | - |
University of Bristol
| 4 years |
Rosnan Bin Rosli | M | 49 |
University of Lancaster
| 4 years |
Bain Slack | M | - |
University of Lancaster
| 1 years |
Martin Stuchtey | M | - |
University of Lancaster
| 1 years |
Mairi Gibbs | M | - |
University of Bristol
| 3 years |
Carlos Sagra | M | - |
University of Bristol
| 3 years |
Gregory Sellers | M | - |
University of Bristol
| 1 years |
Yukiko Kato | F | - |
University of Bristol
| 2 years |
Esther Gibbs | F | 41 |
University of Bristol
| 4 years |
Benjamin Szeto | M | - |
University of Birmingham
| 4 years |
Chloë Sanders | F | - |
University of Bristol
| 4 years |
Chris Lis | M | - |
University of Bristol
| 3 years |
Emma Slater | F | - |
University of Bristol
| 5 years |
Ben Pattison | M | - |
University of Bristol
| 2 years |
Seyhan Pencabligil | M | - |
University of Lancaster
| 1 years |
William Gould | M | - |
University of Bristol
| 3 years |
Kristof Marius Gleich | M | - |
University of Bristol
| 4 years |
Lydia Westmore | F | - |
University of Bristol
| 3 years |
Michael Charles Bristow | M | 47 |
University of Birmingham
| 4 years |
Robert Kavanagh | M | 42 |
University of Bristol
| 4 years |
Kai Wing Shek | M | 52 |
University of Lancaster
| 1 years |
James Glenn Fairweather | M | - |
University of Lancaster
| 4 years |
Sung Tsang | M | 52 |
University of Birmingham
| 2 years |
George Saperas | M | - |
University of Birmingham
| 1 years |
Michelle Yong | F | - |
University of Bristol
| 2 years |
Hung Kee Leung | M | 54 |
University of Lancaster
| 4 years |
Robin Challis | M | - |
University of Bristol
| 3 years |
Mickey Ramalho | M | - |
University of Bristol
| 4 years |
Guy Westlake | M | - |
University of Bristol
| 4 years |
Stephanie Cohn-Rupp | F | - |
University of Bristol
| 3 years |
Andrei Alexandrovich Martianov | M | - |
University of Bristol
| 2 years |
Hugh Spurling | M | - |
University of Bristol
| 4 years |
Matthieu Chevrier | M | - |
University of Bristol
| 1 years |
Christopher Marc Afors | M | 45 |
University of Bristol
| 3 years |
Alison El-Araby | F | - |
University of Bristol
| 4 years |
Riccardo Varrazza | M | - |
University of Bristol
| 3 years |
Sze Chung Chan | M | 54 |
University of Lancaster
| 1 years |
Siu Ngor Lau | F | 60 |
University of Lancaster
| 2 years |
George Bradshaw Russ Godber | M | - |
University of Bristol
| 4 years |
Emmanuel Papadakis | M | - |
University of Bristol
| 4 years |
Alan Preece | M | - |
University of Bristol
| 12 years |
Simon Paul Fairbrass | M | - |
University of Bristol
| 5 years |
Alexander Gebov | M | - |
University of Bristol
| 2 years |
Steven Batchelor | M | 47 |
University of Bristol
| 3 years |
Manolis Emmanovil Liodakis | M | 52 |
University of Birmingham
| 1 years |
Jonathan Nicholson | M | - |
University of Lancaster
| 4 years |
Rozilawati Puan binti Basir | F | 53 |
University of Bristol
| 2 years |
James Matthew Smallridge | M | 48 |
University of Bristol
| 3 years |
Umar Ganda | M | 67 |
University of Lancaster
| 2 years |
Alexander Matytsyn | M | 63 |
University of Bristol
| 2 years |
Helmi Faisal bin Fuad | M | 50 |
University of Birmingham
| 4 years |
Mardiasmo | M | 66 |
University of Birmingham
| 3 years |
Olga Vysotskaya | F | 63 |
University of Bristol
| 2 years |
Mariusz Serwa | M | 53 |
University of Bristol
| 1 years |
Mark Griffiths | M | 59 |
University of Bristol
| 1 years |
Soumya Jain | F | 30 |
University of Bristol
| 14 years |
Steve Dewey | M | - |
University of Bristol
| 2 years |
Alexander West | M | 43 |
University of Bristol
| 3 years |
Beth Hilson | F | - |
University of Bristol
| 4 years |
Steinar Kristoffersen | M | - |
University of Lancaster
| 4 years |
Tai Yeong Yap | M | 56 |
University of Lancaster
| 4 years |
Alex Cosmo Walrond Bonsor | M | - |
University of Bristol
| 4 years |
Alasdair Younie | M | - |
University of Bristol
| 4 years |
Simon Retter | M | 42 |
University of Bristol
| 4 years |
Enkhtuvshin Gombo | F | 53 |
University of Birmingham
| 2 years |
Dung Quang Pham | M | 51 |
University of Birmingham
| 1 years |
Tom Wright | M | - |
University of Bristol
| 3 years |
Murat Bilgiç | M | 56 |
University of Birmingham
| 1 years |
Michael Burgess | M | 61 |
University of Bristol
| 3 years |
Rob J. Mundy | M | - |
University of Bristol
| 4 years |
Ian Goés | M | - |
University of Birmingham
| 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
United Kingdom | 92 | 92.00% |
Germany | 8 | 8.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Martin Crook
- Personal Network